With new antipsychotics and medication regimens continuously introduced in the treatment of schizophrenia, it is important and essential to conduct more clinical trials to confirm and select the ones with the best antipsychotic effect and minimal adverse effects across patients. More research is also needed to provide data on the associations and predictions of specific dose ranges of each effective antipsychotic with the treatment responses of various patient groups, based on individual clinical and illness characteristics